The following post is by The Global Center’s Christine Lubinski, reporting from the 18th International AIDS Conference in Vienna. Michel Sidibe, Director of UNAIDS, and Marcos Espinal, Director of the STOP TB Partnership, signed a memorandum of understanding at a TB/HIV symposium today, pledging to join forces to reduce the human toll of HIV/TB co-infection. […]
The following post is by HIVMA Executive Director Andrea Weddle, reporting from the 18th International AIDS Conference in Vienna. In another late breaker session Thursday, French researcher Blanc presented data supporting early initiation of HIV treatment for patients co-infected with HIV/TB and suggesting it could reduce deaths in co-infected patients by 33 percent. The results […]
The following post is by HIVMA Executive Director Andrea Weddle. She is on location in Vienna, reporting from the 18th International AIDS Conference. South African researcher Meyer-Rath presented compelling data on the cost effectiveness of treating infants early in South Africa at an IAS 2010 late breaker session on Thursday. The findings were based on […]
This post is by the Global Center’s Christine Lubinski, reporting from the International AIDS Conference in Vienna. This is a summary of a report released at a session on Thursday by E. Odoyo-June and colleagues. Kisumu is the third largest city in Kenya and was the site of one of the three critical clinical trials […]
Vienna — “Today, only 4.1 percent of people living with HIV/AIDS are screened for TB,” said RESULTS Executive Director Joanne Carter during a press conference Wednesday at IAS 2010. “And this is despite TB being the most likely infection to kill [HIV infected persons.]” “Failure to provide this screening is malpractice on the grandest scale,” […]
HIV
The following is a guest post by Maureen Luba Milambe, African Regional Advocacy Advisor, AVAC On Tuesday (June 8), the UN General Assembly voted overwhelmingly to […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]